The dawn of a new era for nonalcoholic fatty liver disease?

Affiliations

¹ Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

Editorial

Alessandro Mantovani et al. Hepatobiliary Surg Nutr. 2019 Dec.

. 2019 Dec;8(6):629-631.

doi: 10.21037/hbsn.2019.09.15.

¹ Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver disease.
Barbara M, Scott A, Alkhouri N. Barbara M, et al. Hepatobiliary Surg Nutr. 2018 Oct;7(5):372-381. doi: 10.21037/hbsn.2018.08.05. Hepatobiliary Surg Nutr. 2018. PMID: 30498712 Free PMC article. Review.

1. Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018;15:11-20. 10.1038/nrgastro.2017.109 - DOI - PubMed
1. Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016;65:1038-48. 10.1016/j.metabol.2015.12.012 - DOI - PubMed
1. Anstee QM, Seth D, Day CP. Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease. Gastroenterology 2016;150:1728-44.e7. 10.1053/j.gastro.2016.01.037 - DOI - PubMed
1. Nobili V, Alisi A, Valenti L, et al. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nat Rev Gastroenterol Hepatol 2019;16:517-30. 10.1038/s41575-019-0169-z - DOI - PubMed
1. Eslam M, Valenti L, Romeo S. Genetics and epigenetics of NAFLD and NASH: Clinical impact. J Hepatol 2018;68:268-79. 10.1016/j.jhep.2017.09.003 - DOI - PubMed